Hainan Honz Pharmaceutical Co (300086) — Cash Flow Reinvestment Rate
Hainan Honz Pharmaceutical Co (300086) has a Cash Flow Reinvestment Rate of 0.39x as of June 2025, reinvesting CN¥9.99 Million (capex CN¥4.99 Million plus investments CN¥-4.99 Million) from operating cash flow of CN¥25.84 Million. See 300086 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hainan Honz Pharmaceutical Co Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Hainan Honz Pharmaceutical Co across 17 annual periods. For the full cash flow conversion analysis, see Hainan Honz Pharmaceutical Co (300086) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Hainan Honz Pharmaceutical Co (2007–2025)
Year-by-year capital reinvestment analysis for Hainan Honz Pharmaceutical Co. See Hainan Honz Pharmaceutical Co financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.76x | CN¥92.12 Million | CN¥121.24 Million | CN¥92.12 Million | ▼ -69.2% |
| 2024 | 2.47x | CN¥176.42 Million | CN¥71.46 Million | CN¥92.50 Million | ▼ -11.4% |
| 2023 | 2.79x | CN¥197.04 Million | CN¥70.69 Million | CN¥137.56 Million | ▲ +39.7% |
| 2022 | 1.99x | CN¥58.48 Million | CN¥29.32 Million | CN¥45.10 Million | ▼ -90.9% |
| 2021 | 21.80x | CN¥246.97 Million | CN¥11.33 Million | CN¥219.97 Million | ▲ +315.1% |
| 2019 | 5.25x | CN¥236.65 Million | CN¥45.06 Million | CN¥130.99 Million | ▼ -28.3% |
| 2018 | 7.33x | CN¥1.16 Billion | CN¥157.66 Million | CN¥291.68 Million | ▼ -31.5% |
| 2017 | 10.70x | CN¥194.45 Million | CN¥18.17 Million | CN¥152.85 Million | ▲ +358.2% |
| 2016 | 2.34x | CN¥212.26 Million | CN¥90.88 Million | CN¥41.57 Million | ▲ +224.3% |
| 2015 | 0.72x | CN¥56.39 Million | CN¥78.30 Million | CN¥56.39 Million | ▲ +71.5% |
| 2014 | 0.42x | CN¥31.04 Million | CN¥73.93 Million | CN¥31.04 Million | ▼ -41.4% |
| 2013 | 0.72x | CN¥56.55 Million | CN¥78.93 Million | CN¥56.55 Million | ▲ +54.4% |
| 2012 | 0.46x | CN¥50.81 Million | CN¥109.46 Million | CN¥50.81 Million | ▼ -67.7% |
| 2010 | 1.44x | CN¥114.90 Million | CN¥79.89 Million | CN¥114.90 Million | ▲ +117.6% |
| 2009 | 0.66x | CN¥61.85 Million | CN¥93.58 Million | CN¥61.85 Million | ▲ +21.3% |
| 2008 | 0.54x | CN¥34.10 Million | CN¥62.61 Million | CN¥34.10 Million | ▼ -18.0% |
| 2007 | 0.66x | CN¥20.33 Million | CN¥30.59 Million | CN¥20.33 Million | — |